High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma

Abstract Carbohydrate antigen 19‐9 (CA19‐9) fails to demonstrate the predictive value for early detection pancreatic ductal adenocarcinoma (PDAC). Glypican‐1 (GPC1+) exosomes may serve as a noninvasive diagnostic tool to detect early stages of PDAC. Therefore, it is necessary to explore the serum GP...

Full description

Bibliographic Details
Main Authors: Cong‐ya Zhou, Yi‐ping Dong, Xiao Sun, Xin Sui, Hong Zhu, Ya‐qin Zhao, Yuan‐yuan Zhang, Clifford Mason, Qing Zhu, Su‐xia Han
Format: Article
Language:English
Published: Wiley 2018-11-01
Series:Cancer Medicine
Subjects:
carbohydrate antigen 19‐9
diagnosis
glypican‐1
pancreatic ductal adenocarcinoma
prognosis
serum biomarker
Online Access:https://doi.org/10.1002/cam4.1833

Internet

https://doi.org/10.1002/cam4.1833

Similar Items